203 related articles for article (PubMed ID: 36293542)
1. Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury.
Abu-Tayeh Suleiman H; Said S; Ali Saleh H; Gamliel-Lazarovich A; Haddad E; Minkov I; Zohar Y; Ilan N; Vlodavsky I; Abassi Z; Assady S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293542
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
3. Nephroprotective effect of heparanase in experimental nephrotic syndrome.
Assady S; Alter J; Axelman E; Zohar Y; Sabo E; Litvak M; Kaplan M; Ilan N; Vlodavsky I; Abassi Z
PLoS One; 2015; 10(3):e0119610. PubMed ID: 25786136
[TBL] [Abstract][Full Text] [Related]
4. Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy.
Yi M; Zhang L; Liu Y; Livingston MJ; Chen JK; Nahman NS; Liu F; Dong Z
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F74-F84. PubMed ID: 28404589
[TBL] [Abstract][Full Text] [Related]
5. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
7. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
8. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats.
Chen S; Fang Z; Zhu Z; Deng A; Liu J; Zhang C
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):715-9. PubMed ID: 20037813
[TBL] [Abstract][Full Text] [Related]
10. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
12. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
[TBL] [Abstract][Full Text] [Related]
13. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway.
Dong J; Jiang Z; Ma G
Exp Cell Res; 2020 May; 390(2):111928. PubMed ID: 32156599
[TBL] [Abstract][Full Text] [Related]
15. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC
J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413
[TBL] [Abstract][Full Text] [Related]
18. Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.
Vlodavsky I; Barash U; Nguyen HM; Yang SM; Ilan N
Semin Thromb Hemost; 2021 Apr; 47(3):240-253. PubMed ID: 33794549
[TBL] [Abstract][Full Text] [Related]
19. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass.
Kram V; Zcharia E; Yacoby-Zeevi O; Metzger S; Chajek-Shaul T; Gabet Y; Müller R; Vlodavsky I; Bab I
J Cell Physiol; 2006 Jun; 207(3):784-92. PubMed ID: 16514606
[TBL] [Abstract][Full Text] [Related]
20. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
